Bristol-Myers Squibb's R&D spending 2015-2023
This statistic shows the R&D expenses of pharmaceutical company Bristol-Myers Squibb from 2015 to 2023. In 2023, the company's R&D spending amounted to approximately 9.3 billion U.S. dollars. Bristol-Myers Squibb is headquartered in New York City and is one of the largest pharmaceutical companies worldwide. BMS announced in April 2019 and completed in November 2019 the acquisition of Celgene, thus making one of the largest pharma mega deals in the last few years.